What is the risk of acute cardiovascular complications in adults hospitalized for respiratory syncytial virus (RSV) vs influenza or SARS-CoV-2 Omicron infection?

People with noncommunicable diseases (NCDs) are at a higher risk of contracting vaccine-preventable diseases, such as influenza, with a higher likelihood of severity and complications.

Respiratory infections can increase the risk of cardiovascular diseases among all people. Studies show that for CVD patients diagnosed with flu, the risk of experiencing a heart attack increases 6-fold.

In conclusions recently approved, the Council puts forward a series of measures aimed at improving cardiovascular health in the EU, focusing specifically on prevention, early detection, treatment and rehabilitation.

Vaccination against respiratory viruses can reduce the risk of complications associated with CVDs.

Cardiometabolic outcomes up to 12 months after COVID-19 infection. A matched cohort study in the UK

Pressure Points: Call for simultaneous action on diabetes and hypertension for more resilient health systems

Less than half of patients with chronic health conditions report having been vaccinated against flu